SPHERA FUNDS MANAGEMENT LTD.

Position in SVRA — Savara Inc

CIK 1496201 TEL AVIV, L3

Position in SVRA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,657,970

+$622,135 QoQ

Shares Held

756,164

+2.3% QoQ

Ownership

0.368%

of shares outstanding

% of Portfolio

0.68%

of 13F equity value

Holder Rank

#39

of 181 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,002,188 across 71 Biotechnology names. SVRA ranks #33 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MLYS	Mineralys Therapeutics, Inc.	1,469,971	$39,659,817
2	SNDX	Syndax Pharmaceuticals Inc	1,014,606	$22,179,287
3	RARE	Ultragenyx Pharmaceutical Inc.	588,494	$19,649,814
4	BMRN	Biomarin Pharmaceutical Inc	328,550	$18,799,631
5	CYTK	Cytokinetics Inc	219,987	$18,740,692
6	BBIO	BridgeBio Pharma, Inc.	245,346	$18,273,370
7	COGT	Cogent Biosciences, Inc.	459,340	$17,776,458
8	INSM	INSMED Inc	118,800	$12,666,456

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,657,970	756,164	+2.3%	Shares	Defined	2026-08-14
2026-03-31	$4,035,835	739,164	-37.3%	Shares	Defined	2026-05-15
2025-12-31	$7,104,328	1,178,164	-12.8%	Shares	Defined	2026-02-17
2025-09-30	$4,820,688	1,350,333	+3.1%	Shares	Defined	2025-11-14
2025-06-30	$2,987,331	1,310,233	+2.0%	Shares	Defined	2025-08-14
2025-03-31	$3,557,098	1,284,151	+6.0%	Shares	Defined	2025-05-15
2024-12-31	$3,719,406	1,211,533	+115.2%	Shares	Defined	2025-02-14
2024-09-30	$2,387,573	563,107	-41.5%	Shares	Defined	2024-11-14
2024-06-30	$3,879,628	962,687	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.